Since 1998, Robert Rosen has been a Managing Member of Greyhawke Capital Advisors LLC, a company which invests capital in, and applies management expertise to, selected investment opportunities generally involving net leased real estate properties. Greyhawke has also sponsored investments in multiple multi-family residential projects. Mr. Rosen was recently made a Director of Nouveau Biosciences, […]
Rich Kushel, Senior Managing Director, is the Head of the Portfolio Management Group (PMG), which encompasses BlackRock’s liquid markets, active investing across Fixed Income, Equities and Multi-Asset Strategies. He is a member of the firm’s Global Management Committee, the Global Executive Committee, and co-chair of the GEC Investment Subcommittee. Mr. Kushel’s prior roles include heading […]
Trial and employment attorney for over 30 years Past Federal Prosecutor in the U.S. Attorneys Office for the Eastern District of New York Extensive experience litigating complex cases across private equity and health care.
Owen is the Founder, Chair and Chief Executive Officer of Nouveau Biosciences. Under his leadership, Nouveau Biosciences has matured a platform to drug focused biotechnology company leveraging the latest advances in synthetic lethality screens, genomics and computational biology to produce a pipeline of novel, derisked nanotherapeutic drugs for cancer. Their lead drug candidate, kromastat, has […]